B de Keizer
Overview
Explore the profile of B de Keizer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eertink J, Arens A, Huijbregts J, Celik F, de Keizer B, Stroobants S, et al.
Eur J Nucl Med Mol Imaging
. 2021 Sep;
49(3):943-952.
PMID: 34476551
Purpose: MYC gene rearrangements in diffuse large B-cell lymphoma (DLBCL) patients are associated with poor prognosis. Our aim was to compare patterns of 2[F]fluoro-2-deoxy-D-glucose positron emission tomography computed tomography (PET/CT)...
2.
Alsultan A, Braat A, Smits M, Barentsz M, Bastiaannet R, Bruijnen R, et al.
Clin Oncol (R Coll Radiol)
. 2020 Dec;
33(2):106-116.
PMID: 33358630
Radioembolisation is a locoregional treatment modality for hepatic malignancies. It consists of several stages that are vital to its success, which include a pre-treatment angiographic simulation followed by nuclear medicine...
3.
Lebbink C, Dekker B, Bocca G, Braat A, Derikx J, Dierselhuis M, et al.
Eur J Endocrinol
. 2020 Jul;
183(4):P11-P18.
PMID: 32698145
Background: Currently, there are no European recommendations for the management of pediatric thyroid cancer. Other current international guidelines are not completely concordant. In addition, medical regulations differ between, for instance,...
4.
Tas M, Reedijk A, Karim-Kos H, Kremer L, van de Ven C, Dierselhuis M, et al.
Eur J Cancer
. 2019 Nov;
124:47-55.
PMID: 31726247
Purpose: Long-term trends in neuroblastoma incidence and survival in unscreened populations are unknown. We explored trends in incidence, stage at diagnosis, treatment and survival of neuroblastoma in the Netherlands from...
5.
Kroese T, Goense L, van Hillegersberg R, de Keizer B, Mook S, Ruurda J, et al.
Dis Esophagus
. 2018 Jun;
31(12).
PMID: 29917073
Restaging after neoadjuvant therapy aims to reduce the number of patients undergoing esophagectomy in case of distant (interval) metastases. The aim of this study is to systematically review and meta-analyze...
6.
Dankbaar J, Snijders T, Robe P, Seute T, Eppinga W, Hendrikse J, et al.
J Neurooncol
. 2015 Sep;
125(1):167-75.
PMID: 26384811
In the follow-up of patients treated for high grade glioma, differentiation between progressive disease (PD) and treatment-induced necrosis (TIN) is challenging. The purpose of this study is to evaluate the...
7.
Berger P, Vaartjes I, Scholtens A, Moll F, de Borst G, de Keizer B, et al.
Eur J Vasc Endovasc Surg
. 2015 Jul;
50(3):376-83.
PMID: 26164091
Objective: (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scanning has been suggested as a means to detect vascular graft infections. However, little is known about the typical FDG uptake patterns associated...
8.
Adams H, Kwee T, de Keizer B, Fijnheer R, de Klerk J, Littooij A, et al.
Ann Oncol
. 2013 Dec;
25(5):921-7.
PMID: 24351400
Background: This study aimed to systematically review and meta-analyze published data on the diagnostic performance of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting bone marrow involvement in newly diagnosed...
9.
de Meer S, Dauwan M, de Keizer B, Valk G, Rinkes I, Vriens M
World J Surg
. 2012 Jan;
36(6):1262-7.
PMID: 22270993
Background: Several Japanese studies have focused on identifying prognostic factors in patients with positive lymph nodes to predict recurrence rate and disease-free survival (DFS). However, different treatment protocol is followed...
10.
Verburg F, de Keizer B, de Klerk J, Lentjes E, Lips C, van Isselt J
Nuklearmedizin
. 2009 Feb;
48(1):26-9.
PMID: 19212608
Unlabelled: Measurements of thyroglobulin (Tg) levels 72 h after administration of recombinant human thyrotropin (rhTSH) are recommended by the manufacturer in the follow-up of patients with differentiated thyroid carcinoma (DTC)....